Submission Details
| 510(k) Number | K250135 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 17, 2025 |
| Decision Date | January 16, 2026 |
| Days to Decision | 364 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K250135 is an FDA 510(k) clearance for the WAVE Clinical Platform (2.0.000), a Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (Class II — Special Controls, product code MWI), submitted by Baxter Healthcare Corp/ Excel Medical (Palm Beach Gardens, US). The FDA issued a Cleared decision on January 16, 2026, 364 days after receiving the submission on January 17, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2300.
| 510(k) Number | K250135 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 17, 2025 |
| Decision Date | January 16, 2026 |
| Days to Decision | 364 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | MWI — Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2300 |